210 related articles for article (PubMed ID: 37149661)
21. LncRNA PVT1 promotes the malignant progression of acute myeloid leukaemia via sponging miR-29 family to increase WAVE1 expression.
Cheng J; Song Y; Xu J; Li HH; Zheng JF
Pathology; 2021 Aug; 53(5):613-622. PubMed ID: 33558065
[TBL] [Abstract][Full Text] [Related]
22. MiR-592 functions as a tumor suppressor in acute myeloid leukemia by targeting ROCK1 and predicts patients' prognosis.
Xu Y; Li K; Wang SB; Yang SG
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1610-1619. PubMed ID: 30840284
[TBL] [Abstract][Full Text] [Related]
23. Silencing long non-coding RNA XIST suppresses drug resistance in acute myeloid leukemia through down-regulation of MYC by elevating microRNA-29a expression.
Wang C; Li L; Li M; Wang W; Liu Y; Wang S
Mol Med; 2020 Nov; 26(1):114. PubMed ID: 33228517
[TBL] [Abstract][Full Text] [Related]
24. Tumor suppressor miR-139-5p targets Tspan3 and regulates the progression of acute myeloid leukemia through the PI3K/Akt pathway.
Zhang R; Tang P; Wang F; Xing Y; Jiang Z; Chen S; Meng X; Liu L; Cao W; Zhao H; Ma P; Chen Y; An C; Sun L
J Cell Biochem; 2019 Mar; 120(3):4423-4432. PubMed ID: 30367526
[TBL] [Abstract][Full Text] [Related]
25. CLPs-miR-103a-2-5p inhibits proliferation and promotes cell apoptosis in AML cells by targeting LILRB3 and Nrf2/HO-1 axis, regulating CD8 + T cell response.
Cen Q; Chen J; Guo J; Chen M; Wang H; Wu S; Zhang H; Xie X; Li Y
J Transl Med; 2024 Mar; 22(1):278. PubMed ID: 38486250
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA SENCR facilitates the progression of acute myeloid leukemia through the miR-4731-5p/IRF2 pathway.
Han C; Qi Y; She Y; Zhang M; Xie H; Zhang J; Zhao Z; Peng C; Liu Y; Lin Y; Wang J; Zeng D
Pathol Res Pract; 2023 May; 245():154483. PubMed ID: 37120908
[TBL] [Abstract][Full Text] [Related]
27. Circular RNA circ_0005774 contributes to proliferation and suppresses apoptosis of acute myeloid leukemia cells via circ_0005774/miR-192-5p/ULK1 ceRNA pathway.
Li Q; Luan Q; Zhu H; Zhao Y; Ji J; Wu F; Yan J
Biochem Biophys Res Commun; 2021 Apr; 551():78-85. PubMed ID: 33735626
[TBL] [Abstract][Full Text] [Related]
28. Transcriptome-wide analysis uncovers the targets of the RNA-binding protein MSI2 and effects of MSI2's RNA-binding activity on IL-6 signaling.
Duggimpudi S; Kloetgen A; Maney SK; Münch PC; Hezaveh K; Shaykhalishahi H; Hoyer W; McHardy AC; Lang PA; Borkhardt A; Hoell JI
J Biol Chem; 2018 Oct; 293(40):15359-15369. PubMed ID: 30126842
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA UCA1 modulates cell proliferation and apoptosis by regulating miR-296-3p/Myc axis in acute myeloid leukemia.
Li J; Wang M; Chen X
Cell Cycle; 2020 Jun; 19(12):1454-1465. PubMed ID: 32286143
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-494 Activation Suppresses Bone Marrow Stromal Cell-Mediated Drug Resistance in Acute Myeloid Leukemia Cells.
Tian C; Zheng G; Zhuang H; Li X; Hu D; Zhu L; Wang T; You MJ; Zhang Y
J Cell Physiol; 2017 Jun; 232(6):1387-1395. PubMed ID: 27696394
[TBL] [Abstract][Full Text] [Related]
31. Small-sized extracellular vesicles (EVs) derived from acute myeloid leukemia bone marrow mesenchymal stem cells transfer miR-26a-5p to promote acute myeloid leukemia cell proliferation, migration, and invasion.
Ji D; He Y; Lu W; Rong Y; Li F; Huang X; Huang R; Jiang Y; Chen G
Hum Cell; 2021 May; 34(3):965-976. PubMed ID: 33620671
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-143/Musashi-2/KRAS cascade contributes positively to carcinogenesis in human bladder cancer.
Tsujino T; Sugito N; Taniguchi K; Honda R; Komura K; Yoshikawa Y; Takai T; Minami K; Kuranaga Y; Shinohara H; Tokumaru Y; Heishima K; Inamoto T; Azuma H; Akao Y
Cancer Sci; 2019 Jul; 110(7):2189-2199. PubMed ID: 31066120
[TBL] [Abstract][Full Text] [Related]
33. MiR-1306-5p promotes cell proliferation and inhibits cell apoptosis in acute myeloid leukemia by downregulating PHF6 expression.
Gao X; Fan S; Zhang X
Leuk Res; 2022 Sep; 120():106906. PubMed ID: 35780573
[TBL] [Abstract][Full Text] [Related]
34. Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia.
Kharas MG; Lengner CJ; Al-Shahrour F; Bullinger L; Ball B; Zaidi S; Morgan K; Tam W; Paktinat M; Okabe R; Gozo M; Einhorn W; Lane SW; Scholl C; Fröhling S; Fleming M; Ebert BL; Gilliland DG; Jaenisch R; Daley GQ
Nat Med; 2010 Aug; 16(8):903-8. PubMed ID: 20616797
[TBL] [Abstract][Full Text] [Related]
35. Tumor-suppressing effects of miR-381-3p in pediatric acute myeloid leukemia via ROCK1 downregulation.
Ye Q; Ying Q; Dai Q; Liao C; Xiao G
Funct Integr Genomics; 2023 Jan; 23(1):43. PubMed ID: 36658407
[TBL] [Abstract][Full Text] [Related]
36. Transcription factor C/EBPα-induced microRNA-30c inactivates Notch1 during granulopoiesis and is downregulated in acute myeloid leukemia.
Katzerke C; Madan V; Gerloff D; Bräuer-Hartmann D; Hartmann JU; Wurm AA; Müller-Tidow C; Schnittger S; Tenen DG; Niederwieser D; Behre G
Blood; 2013 Oct; 122(14):2433-42. PubMed ID: 23974200
[TBL] [Abstract][Full Text] [Related]
37. miR-338-3p Plays a Significant Role in Casticin-Induced Suppression of Acute Myeloid Leukemia via Targeting PI3K/Akt Pathway.
Yu K; Wang J; Hou J; Zhang L; Liang H
Biomed Res Int; 2022; 2022():9214130. PubMed ID: 35765408
[TBL] [Abstract][Full Text] [Related]
38. microRNA-146a Promotes Growth of Acute Leukemia Cells by Downregulating Ciliary Neurotrophic Factor Receptor and Activating JAK2/STAT3 Signaling.
Wang L; Zhang H; Lei D
Yonsei Med J; 2019 Oct; 60(10):924-934. PubMed ID: 31538427
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia.
Thol F; Winschel C; Sonntag AK; Damm F; Wagner K; Chaturvedi A; Göhring G; Schlegelberger B; Lübbert M; Fiedler W; Kirchner H; Krauter J; Ganser A; Heuser M
Ann Hematol; 2013 Mar; 92(3):315-23. PubMed ID: 23233047
[TBL] [Abstract][Full Text] [Related]
40. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
